Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5Y20
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,091
Award facts
- Contract value 100% obligated
- $28,091.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,091.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 7.5 mg/0.5 ml pen injections on January 15, 2026, with an ultimate completion date of January 16, 2026. The contract was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc., is a critical vendor in the federal medical supply chain, particularly for the Defense Health Agency and military healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to deliver a comprehensive range of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. This delivery order for Zepbound, a GLP-1 receptor agonist indicated for weight management, reflects continued federal procurement of diabetes and metabolic disorder treatments through the DLA's established pharmaceutical supply relationships.
Quick answers
Who was awarded contract SPE2DR26F5Y20?
SPE2DR26F5Y20 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F5Y20 worth?
The government has obligated $28,091 on SPE2DR26F5Y20.
Is contract SPE2DR26F5Y20 an order under another contract?
Yes. SPE2DR26F5Y20 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5Y20 competed?
The extent of competition for SPE2DR26F5Y20 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award